PhRMA, BIO, MIWG File Petition To Block FDA's Intended Use Rule
February 16, 2017
Three major industry groups are attempting to indefinitely halt FDA's controversial intended use final rule, which they say violates the Administrative Procedure Act, creates a "new and unjustified legal standard" for determining intended use, and could impact public health by limiting scientific discussion about medical products. The groups filed a petition asking the agency to revert back to less controversial language included in the 2015 proposed rule. The rule was originally slated to go into effect Feb. 8, but was...
Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting as the Trump administration and congressional Republicans take on the dismantling and replacement of the Affordable Care Act.